ISLMF.US InSilico Medicine Cayman TopCo

Healthcare Biotechnology USA Stocks
- USD
Market cap
-
P/E
-
P/B
5.11x
ROE
-77.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is ISLMF.US undervalued?

Graham number

The Graham number of InSilico Medicine Cayman TopCo cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

InSilico Medicine Cayman TopCo fundamental analysis

No fundamental analysis for InSilico Medicine Cayman TopCo yet.

InSilico Medicine Cayman TopCo stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About InSilico Medicine Cayman TopCo

InSilico Medicine Cayman TopCo engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. The company offers Pharma.AI, an AI-powered drug discovery and development platform offering new target identification, small molecule generation, and clinical outcome prediction services. Its pipeline covers solutions for fibrosis, oncology, immunology, metabolic, anti-pain, and other therapeutic areas. The comp…

Full company profile